Jump to Navigation

Prostate Cancer Survival Improved with PSA Testing

Photo of Armand Leone

Prostate cancer survival for men with metastatic disease significantly improved with routine Prostate Specific Antigen (PSA) testing over the last 20 years, despite a current US Preventive Task Force's (USPTA) recommendation against general screening. A study in the Journal of Urology showed a significant reduction in the stage severity of the cancer in men who followed with testing. Overall survivability increased for men with metastatic disease who underwent screening, especially black American men. The study leaves no doubt that PSA testing plays a role in extending lives for such patients. It also supports the use of PSA testing for general screening in asymptomatic patients.

There has been a lot of controversy about the USPTA's recommendation against testing. The government claims that the benefits of testing are outweighed by the harm and cost of doing biopsies many of which are negative. Dr. Wilt who was one of the authors of the USPTA recommendation felt that the study was interesting but that increased survival could be due to many factors other than the PSA test. However physicians have used PSA testing for the last 20 years and many still consider it an important part of preventive care.

Early diagnosis cancer is the most important factor for better outcomes with often less invasive treatment and improved survivability. A delay or failure to diagnose cancer caused by failing to properly screen a patient for prostate cancer by way of history, examination and testing can cause irreparable harm with a poorer outcome. Rectal examination with careful prostate palpation by an experienced clinician is a proper part of prostate care. Monitoring for signs of urinary problems, such as obstruction of flow, and reporting changes to physicians are important. The specific medical facts of each case are important in determining if PSA testing should be done.

No Comments

Leave a comment
Comment Information

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

"The mission of Britcher Leone, LLC is to unite the professional disciplines of medicine and law to help the victims of physicians' malpractice and serious personal injury restore their future and the future of their families." RSS FindLaw Network
Verdicts & Settlements
  • $1,237,004 Verdict for Failure to Properly Treat
  • $42 Million Dollar Vaccine Injury Structured Settlement
  • $5.7 Million Obstetrical Malpractice Structured Settlement
  • $3.8 Million Present Value Pediatric Urological Surgery Settlement
  • $3.38 Million Gross Medical Malpractice Verdict
  • $1.65 Million Present Value Spinal Surgery Settlement
  • $5.2 Million Obstetrical Malpractice Structured Settlement
  • $40 Million Vaccine Structured Award
  • $19 Million Vaccine Structured Award
  • $2.5 Million Failure to Timely Diagnose Breast Cancer Verdict
  • $16 Million Obstetrical Malpractice Structured Settlement
  • $13.6 Million Obstetrical Malpractice Structured Settlement
  • $3.5 Million Resort Negligence Settlement
  • $60 Million Flu Vaccine Structured Settlement
  • $2 Million Wrongful Birth/Wrongful Life Settlement
  • $3.5 Million Present Value Wrongful Death Settlement
  • $1.59 Million Medical Malpractice Judgment
  • $800,000 Recovery Failure to Treat Eye Infection and Vision Loss
  • $1.35 Million Wrongful Death Settlement
  • $1.2 Million Failure to Provide Adequate Security Settlement
  • $850,000 Settlement for Brachial Plexus/Shoulder Dystocia Injury
  • $1 Million Podiatric Malpractice Judgment
  • $863,000 Orthopedic Malpractice Judgment
  • $850,000 Radiology Malpractice Settlement
  • $800,000 Cardiology Malpractice/Wrongful Death Settlement
View All Verdicts
Google+ LinkedIn Uniting Medicine & Law | Rebuilding Your Future